Journal of Medicinal Chemistry 2007-11-15

Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy.

Alberto Venturelli, Donatella Tondi, Laura Cancian, Federica Morandi, Giuseppe Cannazza, Bernardetta Segatore, Fabio Prati, Gianfranco Amicosante, Brian K Shoichet, M Paola Costi

Index: J. Med. Chem. 50 , 5644, (2007)

Full Text: HTML

Abstract

Benzo[b]thiophene-2-ylboronic acid, 1, is a 27 nM inhibitor of the class C beta-lactamase AmpC and potentiates the activity of beta-lactam antibiotics in bacteria that express this and related enzymes. As is often true, the potency of compound 1 against the enzymes is much attenuated in cell culture against Gram negative bacteria, where the minimum inhibitor concentration of compound 1 is in the mid-micromolar range. Here, we modulated the properties of this lead to enhance its ability to cross the membrane, using a combination of X-ray crystallography, structure-based design, and application of physical models of outer membrane crossing. This strategy led us to derivatives with substantially improved permeability. Also, the greater solubility of these compounds allowed us to measure their efficacy at higher concentrations than with the lead 1, leading to higher maximum potentiation of the antibiotic effect of ceftazidime on resistant bacteria.